DK2545189T3 - COMPLETE COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE - Google Patents
COMPLETE COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE Download PDFInfo
- Publication number
- DK2545189T3 DK2545189T3 DK11709836.8T DK11709836T DK2545189T3 DK 2545189 T3 DK2545189 T3 DK 2545189T3 DK 11709836 T DK11709836 T DK 11709836T DK 2545189 T3 DK2545189 T3 DK 2545189T3
- Authority
- DK
- Denmark
- Prior art keywords
- sequence
- target
- pcr
- nucleic acid
- reaction mixture
- Prior art date
Links
- 230000000903 blocking effect Effects 0.000 title claims description 112
- 238000000034 method Methods 0.000 claims description 69
- 150000007523 nucleic acids Chemical group 0.000 claims description 69
- 239000011541 reaction mixture Substances 0.000 claims description 63
- 108020004414 DNA Proteins 0.000 claims description 58
- 102000039446 nucleic acids Human genes 0.000 claims description 58
- 108020004707 nucleic acids Proteins 0.000 claims description 58
- 238000002844 melting Methods 0.000 claims description 37
- 230000008018 melting Effects 0.000 claims description 36
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 36
- 230000003321 amplification Effects 0.000 claims description 35
- 239000000523 sample Substances 0.000 claims description 34
- 230000000295 complement effect Effects 0.000 claims description 24
- 238000004925 denaturation Methods 0.000 claims description 19
- 230000036425 denaturation Effects 0.000 claims description 19
- 230000035772 mutation Effects 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 15
- 125000003729 nucleotide group Chemical group 0.000 claims description 15
- 102000053602 DNA Human genes 0.000 claims description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 9
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 8
- 238000000137 annealing Methods 0.000 claims description 7
- 238000003753 real-time PCR Methods 0.000 claims description 7
- 238000012163 sequencing technique Methods 0.000 claims description 7
- 230000027455 binding Effects 0.000 claims description 6
- 108010006785 Taq Polymerase Proteins 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 2
- 238000007847 digital PCR Methods 0.000 claims description 2
- 238000012165 high-throughput sequencing Methods 0.000 claims description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 claims description 2
- 238000012175 pyrosequencing Methods 0.000 claims description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 2
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims 1
- 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 claims 1
- 239000013615 primer Substances 0.000 description 56
- 108700028369 Alleles Proteins 0.000 description 27
- 108091034117 Oligonucleotide Proteins 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 14
- 238000009396 hybridization Methods 0.000 description 14
- 108700025694 p53 Genes Proteins 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 9
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000002381 plasma Anatomy 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 238000007480 sanger sequencing Methods 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 108091093088 Amplicon Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010069754 Acquired gene mutation Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000011987 methylation Effects 0.000 description 3
- 238000007069 methylation reaction Methods 0.000 description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000037439 somatic mutation Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000001046 green dye Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 101100020619 Arabidopsis thaliana LATE gene Proteins 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 108010022901 Heparin Lyase Proteins 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000205156 Pyrococcus furiosus Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- 108010085671 Thermus thermophilus DNA polymerase Proteins 0.000 description 1
- 108010001244 Tli polymerase Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000007846 asymmetric PCR Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- -1 nucleoside triphosphates Chemical class 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 230000037048 polymerization activity Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/107—Temperature of melting, i.e. Tm
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31164210P | 2010-03-08 | 2010-03-08 | |
| PCT/US2011/027473 WO2011112534A1 (en) | 2010-03-08 | 2011-03-08 | Full cold-pcr enrichment with reference blocking sequence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2545189T3 true DK2545189T3 (en) | 2018-04-23 |
Family
ID=43983637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11709836.8T DK2545189T3 (en) | 2010-03-08 | 2011-03-08 | COMPLETE COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US8623603B2 (OSRAM) |
| EP (1) | EP2545189B1 (OSRAM) |
| JP (1) | JP5795341B2 (OSRAM) |
| KR (2) | KR101550489B1 (OSRAM) |
| CN (1) | CN102859003B (OSRAM) |
| AU (1) | AU2011224534B2 (OSRAM) |
| CA (1) | CA2792433C (OSRAM) |
| DK (1) | DK2545189T3 (OSRAM) |
| ES (1) | ES2665500T3 (OSRAM) |
| WO (1) | WO2011112534A1 (OSRAM) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2545189T3 (en) | 2010-03-08 | 2018-04-23 | Dana Farber Cancer Inst Inc | COMPLETE COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE |
| DK2633071T3 (en) | 2010-10-27 | 2017-01-30 | Harvard College | COMPOSITIONS OF "MAINTENANCE" PRIMER DUPLEXES AND METHODS OF USE |
| EP2681332A1 (en) | 2011-02-28 | 2014-01-08 | Transgenomic, Inc. | Kit and method for sequencing a target dna in a mixed population |
| EP2691541B1 (en) * | 2011-03-31 | 2017-10-18 | Dana-Farber Cancer Institute, Inc. | Method for enriching in single-stranded mutant sequences from mixture of wild-type and mutant sequences |
| US9796748B2 (en) | 2011-05-02 | 2017-10-24 | President And Fellows Of Harvard College | Spatial sequestration of dynamic nucleic acid circuits |
| EP2758458A4 (en) | 2011-07-10 | 2015-10-21 | Harvard College | COMPOSITIONS AND METHODS FOR SELF-ASSEMBLING POLYMERS WITH COMPLEMENTARY MACROSCOPIC AND MICROSCOPIC SCALE UNITS |
| CN103131756B (zh) * | 2011-11-24 | 2014-08-27 | 百奥迈科生物技术有限公司 | 一种小核酸的检测方法及其应用 |
| JP5846496B2 (ja) * | 2012-04-19 | 2016-01-20 | 国立大学法人 鹿児島大学 | ＬＮＡクランプ技術による植物内生菌のＳＳＵｒＲＮＡ遺伝子の選択的ＰＣＲ増幅法 |
| US9133490B2 (en) | 2012-05-16 | 2015-09-15 | Transgenomic, Inc. | Step-up method for COLD-PCR enrichment |
| US9279146B2 (en) | 2012-12-21 | 2016-03-08 | Roche Molecular Systems, Inc. | Compounds and methods for the enrichment of mutated nucleic acid from a mixture |
| EP2948564B1 (en) | 2013-01-23 | 2019-04-10 | Brandeis University | Reagents for improving pcr accuracy |
| WO2015013166A1 (en) | 2013-07-24 | 2015-01-29 | Dana-Farber Cancer Institute, Inc. | Methods and compositions to enable enrichment of minor dna alleles by limiting denaturation time in pcr or simply enable enrichment of minor dna alleles by limiting denaturation time in pcr |
| AU2014329454B2 (en) | 2013-10-03 | 2019-01-17 | Janssen Biotech, Inc. | Protoxin-II variants and methods of use |
| US20160115556A1 (en) * | 2013-10-19 | 2016-04-28 | Trovagene, Inc. | Detecting mutations in disease over time |
| CA2926722A1 (en) * | 2013-10-19 | 2015-04-23 | Trovagene, Inc. | Detecting mutations in disease over time |
| JP2016535987A (ja) | 2013-10-20 | 2016-11-24 | トローバジーン インコーポレイテッド | 核酸配列の合成及び濃縮 |
| WO2015073163A2 (en) * | 2013-11-14 | 2015-05-21 | Trovagene, Inc. | Synthesis and enrichment of nucleic acid sequences |
| US9873908B2 (en) | 2013-11-27 | 2018-01-23 | Roche Molecular Systems, Inc. | Methods for the enrichment of mutated nucleic acid from a mixture |
| CN103602748A (zh) * | 2013-11-28 | 2014-02-26 | 瑞希基因科技（北京）股份有限公司 | 一种结合荧光定量pcr技术的焦磷酸测序方法 |
| WO2015112974A1 (en) * | 2014-01-27 | 2015-07-30 | The General Hospital Corporation | Methods of preparing nucleic acids for sequencing |
| WO2015196154A1 (en) * | 2014-06-20 | 2015-12-23 | Richardson Katherine | System, method, data module and kit for detecting variant nucleotide sequences |
| KR20170134542A (ko) | 2015-04-02 | 2017-12-06 | 얀센 바이오테크 인코포레이티드 | 프로톡신-ii 변이체 및 사용 방법 |
| AU2016250529A1 (en) * | 2015-04-20 | 2017-11-30 | Neogenomics Laboratories, Inc. | Method to increase sensitivity of next generation sequencing |
| ES2917175T3 (es) | 2015-06-24 | 2022-07-07 | Dana Farber Cancer Inst Inc | Degradación selectiva de ADN de tipo salvaje y enriquecimiento de alelos mutantes usando nucleasa |
| CN105063208B (zh) * | 2015-08-10 | 2018-03-06 | 北京吉因加科技有限公司 | 一种血浆中游离的目标dna低频突变富集测序方法 |
| WO2017070339A1 (en) * | 2015-10-20 | 2017-04-27 | Richardson Katherine | Microfluidic device for enrichment of nucleic acid sequence alterations |
| CN107338240B (zh) * | 2015-11-25 | 2020-11-24 | 葛猛 | 对样品中目标核酸序列进行偏向扩增的方法和试剂盒 |
| CN105821120B (zh) * | 2016-02-03 | 2019-04-30 | 广州医科大学附属肿瘤医院 | 一种基于巢式复合cold-pcr的t790m突变检测方法 |
| CA3046953A1 (en) | 2016-12-12 | 2018-06-21 | Dana Farber Cancer Institute, Inc. | Compositions and methods for molecular barcoding of dna molecules prior to mutation enrichment and/or mutation detection |
| ES2882608T3 (es) | 2017-04-23 | 2021-12-02 | Illumina Inc | Composiciones y métodos para mejorar la identificación de muestras en bibliotecas de ácidos nucleicos indexados |
| EP3615671B1 (en) | 2017-04-23 | 2021-07-21 | Illumina Cambridge Limited | Compositions and methods for improving sample identification in indexed nucleic acid libraries |
| ES2929837T3 (es) | 2017-04-23 | 2022-12-02 | Illumina Cambridge Ltd | Composiciones y métodos para mejorar la identificación de muestras en bibliotecas de ácidos nucleicos indexados |
| WO2018197950A1 (en) * | 2017-04-23 | 2018-11-01 | Illumina Cambridge Limited | Compositions and methods for improving sample identification in indexed nucleic acid libraries |
| WO2019023243A1 (en) | 2017-07-24 | 2019-01-31 | Dana-Farber Cancer Institute, Inc. | METHODS AND COMPOSITIONS FOR SELECTING AND AMPLIFYING DNA TARGETS IN A SINGLE REACTION MIXTURE |
| CN107858401A (zh) * | 2017-10-31 | 2018-03-30 | 重庆邮电大学 | 一种低丰度基因突变的富集方法 |
| WO2020156549A1 (en) | 2019-02-02 | 2020-08-06 | Beijing Bytedance Network Technology Co., Ltd. | Buffer access methods for intra block copy in video coding |
| KR20210123300A (ko) | 2019-02-02 | 2021-10-13 | 베이징 바이트댄스 네트워크 테크놀로지 컴퍼니, 리미티드 | 비디오 코딩에서 인트라 블록 복사를 위한 버퍼 관리 |
| WO2020177661A1 (en) | 2019-03-01 | 2020-09-10 | Beijing Bytedance Network Technology Co., Ltd. | Order-based updating for intra block copy in video coding |
| CN117395439A (zh) | 2019-03-01 | 2024-01-12 | 北京字节跳动网络技术有限公司 | 用于视频编解码中的帧内块复制的基于方向的预测 |
| CN117640927A (zh) | 2019-03-04 | 2024-03-01 | 北京字节跳动网络技术有限公司 | 视频编解码中的帧内块复制中的实施方式方面 |
| CA3146016C (en) | 2019-07-06 | 2024-05-07 | Beijing Bytedance Network Technology Co., Ltd. | Virtual prediction buffer for intra block copy in video coding |
| CN114175633B (zh) | 2019-07-10 | 2023-12-29 | 北京字节跳动网络技术有限公司 | 用于视频编解码中的帧内块复制的样点标识 |
| WO2021034999A1 (en) | 2019-08-21 | 2021-02-25 | Dana-Farber Cancer Institute, Inc. | Multi-site enrichment of deletions in dna microsatellites |
| US20240401122A1 (en) * | 2021-09-13 | 2024-12-05 | Nexgen Cancer Detection Llc | Methods for detecting a target polynucleotide in a sample |
| WO2025079958A1 (ko) * | 2023-10-11 | 2025-04-17 | 고려대학교 산학협력단 | 높은 처리량의 돌연변이 특이적 아답터 리게이션 방법 |
Family Cites Families (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US5310652A (en) | 1986-08-22 | 1994-05-10 | Hoffman-La Roche Inc. | Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription |
| US5541308A (en) | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
| CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
| GB2228086A (en) | 1988-11-25 | 1990-08-15 | Ici Plc | Characterisation of genomic DNA |
| KR920700360A (ko) | 1989-03-22 | 1992-02-19 | 하리크 프리드리히 | 미끄럼 베어링 |
| US5075217A (en) | 1989-04-21 | 1991-12-24 | Marshfield Clinic | Length polymorphisms in (dC-dA)n ·(dG-dT)n sequences |
| WO1990013668A1 (en) | 1989-05-05 | 1990-11-15 | Lifecodes Corporation | Method for genetic analysis of a nucleic acid sample |
| US5256775A (en) * | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
| CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
| US5045450A (en) | 1989-07-13 | 1991-09-03 | Massachusetts Institute Of Technology | Determination of a mutational spectrum |
| DE3938907C2 (de) | 1989-11-24 | 1999-11-04 | Dade Behring Marburg Gmbh | Mittel zum Lagern und Suspendieren von Zellen, insbesondere Erythrozyten |
| US5427930A (en) | 1990-01-26 | 1995-06-27 | Abbott Laboratories | Amplification of target nucleic acids using gap filling ligase chain reaction |
| EP0439182B1 (en) | 1990-01-26 | 1996-04-24 | Abbott Laboratories | Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions |
| AU638568B2 (en) | 1990-02-26 | 1993-07-01 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A method for the fluorescent detection of a dna sequence in real time |
| WO1991014003A2 (en) | 1990-03-09 | 1991-09-19 | Ig Laboratories, Inc. | Characterization and analysis of polymorphic vntr loci |
| CA2116215C (en) | 1990-05-07 | 1998-12-22 | Tapestry Pharmaceuticals, Inc. | Diagnostic applications of double d-loop formation |
| US5846710A (en) | 1990-11-02 | 1998-12-08 | St. Louis University | Method for the detection of genetic diseases and gene sequence variations by single nucleotide primer extension |
| US5994056A (en) | 1991-05-02 | 1999-11-30 | Roche Molecular Systems, Inc. | Homogeneous methods for nucleic acid amplification and detection |
| US5648211A (en) | 1994-04-18 | 1997-07-15 | Becton, Dickinson And Company | Strand displacement amplification using thermophilic enzymes |
| GB2293238A (en) | 1994-09-13 | 1996-03-20 | Inceltec Ltd | Primers for replication and/or amplification reactions |
| US5629178A (en) * | 1994-10-28 | 1997-05-13 | Genetics & Ivf Institute | Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA) |
| US5565340A (en) | 1995-01-27 | 1996-10-15 | Clontech Laboratories, Inc. | Method for suppressing DNA fragment amplification during PCR |
| US5631147A (en) | 1995-09-21 | 1997-05-20 | Becton, Dickinson And Company | Detection of nucleic acids in cells by thermophilic strand displacement amplification |
| US6143495A (en) | 1995-11-21 | 2000-11-07 | Yale University | Unimolecular segment amplification and sequencing |
| US5612473A (en) | 1996-01-16 | 1997-03-18 | Gull Laboratories | Methods, kits and solutions for preparing sample material for nucleic acid amplification |
| US6010878A (en) | 1996-05-20 | 2000-01-04 | Smithkline Beecham Corporation | Interleukin-1 β converting enzyme like apoptotic protease-6 |
| US6599704B2 (en) | 1997-03-04 | 2003-07-29 | Christoph Wagener | Method for detecting mutated alleles |
| US5849497A (en) * | 1997-04-03 | 1998-12-15 | The Research Foundation Of State University Of New York | Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker |
| JP3785517B2 (ja) | 1997-06-05 | 2006-06-14 | 東ソー株式会社 | 核酸融解温度測定法 |
| WO1999014226A2 (en) | 1997-09-12 | 1999-03-25 | Exiqon A/S | Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues |
| US6174680B1 (en) | 1998-12-30 | 2001-01-16 | Dana-Farber Cancer Institute, Inc. | Method for identifying mismatch repair glycosylase reactive sites, compounds and uses thereof |
| FR2779154B1 (fr) | 1998-05-27 | 2002-07-12 | Bio Merieux | Procede d'amplification d'au moins une sequence nucleotidique particuliere et amorces de mise en oeuvre |
| US6994962B1 (en) | 1998-12-09 | 2006-02-07 | Massachusetts Institute Of Technology | Methods of identifying point mutations in a genome |
| US6850846B2 (en) | 2000-01-11 | 2005-02-01 | Affymetrix, Inc. | Computer software for genotyping analysis using pattern recognition |
| DE10012540B4 (de) | 2000-03-15 | 2004-09-23 | Vermicon Ag | Oligonukleotide und Verfahren zum spezifischen Nachweis von Mikroorganismen durch Polymerase-Kettenreaktion |
| WO2002018659A2 (en) | 2000-08-30 | 2002-03-07 | Haplogen, Llc | Method for determining alleles |
| EP1253205A1 (en) | 2001-04-24 | 2002-10-30 | LION Bioscience AG | Method of blocking amplification of selected sequences |
| US6762049B2 (en) | 2001-07-05 | 2004-07-13 | Institute Of Microelectronics | Miniaturized multi-chamber thermal cycler for independent thermal multiplexing |
| DE10158516A1 (de) | 2001-11-29 | 2003-06-12 | Focusgenomics Gmbh | Verfahren zum Nachweis von Hybridisierungsereignissen in Nukleinsäuren |
| AUPS076902A0 (en) | 2002-02-26 | 2002-03-21 | Commonwealth Scientific And Industrial Research Organisation | Novel selective polymerase chain reaction |
| AUPS076802A0 (en) | 2002-02-26 | 2002-03-21 | Commonwealth Scientific And Industrial Research Organisation | Selective nucleic acid amplification |
| EP1499745B1 (en) | 2002-04-26 | 2016-11-23 | University of Utah Research Foundation | Characterization of single stranded nucleic acids by melting analysis of secondary structure using double strand-specific nucleic acid dye |
| US20040022764A1 (en) * | 2002-07-31 | 2004-02-05 | Hanan Polansky | Inhibition of microcompetition with a foreign polynucleotide as treatment of chronic disease |
| AU2003289651A1 (en) | 2002-12-18 | 2004-07-09 | Dingbang Xu | Pcr method and application by transnormal low thermo-denaturation temperature |
| US7306913B2 (en) * | 2002-12-20 | 2007-12-11 | Applera Corporation | Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof |
| GB0406863D0 (en) | 2004-03-26 | 2004-04-28 | Qiagen As | Nucleic acid sequencing |
| US7749707B2 (en) | 2005-03-01 | 2010-07-06 | Wako Pure Chemical Industries, Ltd. | Method for obtaining subtraction polynucleotide |
| US7456281B2 (en) * | 2005-04-20 | 2008-11-25 | Idaho Technology, Inc. | Nucleic acid melting analysis with saturation dyes |
| WO2007047572A2 (en) | 2005-10-14 | 2007-04-26 | Cleveland State University | Methods for identifying multiple dna alteration markers in a large background of wild-type dna |
| US20070154892A1 (en) | 2005-12-30 | 2007-07-05 | Simon Wain-Hobson | Differential amplification of mutant nucleic acids by PCR in a mixure of nucleic acids |
| EP1987162A4 (en) | 2006-01-23 | 2009-11-25 | Population Genetics Technologi | NUCLEIC ACID ANALYSIS ABOUT SEQUENCE TOKENS |
| US20100009355A1 (en) * | 2006-03-14 | 2010-01-14 | Kolodney Michael S | Selective amplification of minority mutations using primer blocking high-affinity oligonucleotides |
| CN101443458B (zh) | 2006-03-28 | 2014-04-02 | 联邦科学及工业研究组织 | 扩增dna片段 |
| US20080269068A1 (en) | 2007-02-06 | 2008-10-30 | President And Fellows Of Harvard College | Multiplex decoding of sequence tags in barcodes |
| EP2395113A1 (en) | 2007-06-29 | 2011-12-14 | Population Genetics Technologies Ltd. | Methods and compositions for isolating nucleic acid sequence variants |
| AU2008282780B2 (en) | 2007-08-01 | 2014-04-17 | Dana- Farber Cancer Institute | Enrichment of a target sequence |
| US8071338B2 (en) * | 2007-08-08 | 2011-12-06 | Roche Molecular Systems, Inc. | Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5′-3′ nuclease activity |
| WO2010065626A1 (en) | 2008-12-02 | 2010-06-10 | Globeimmune, Inc. | Genotyping tools, methods and kits |
| US8206929B2 (en) * | 2009-01-07 | 2012-06-26 | Roche Molecular Systems, Inc. | Nucleic acid amplification with allele-specific suppression of sequence variants |
| EP2456887B1 (en) | 2009-07-21 | 2015-11-25 | Gen-Probe Incorporated | Methods and compositions for quantitative detection of nucleic acid sequences over an extended dynamic range |
| DK2545189T3 (en) | 2010-03-08 | 2018-04-23 | Dana Farber Cancer Inst Inc | COMPLETE COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE |
| EP2681332A1 (en) | 2011-02-28 | 2014-01-08 | Transgenomic, Inc. | Kit and method for sequencing a target dna in a mixed population |
| WO2012129363A2 (en) | 2011-03-24 | 2012-09-27 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
| EP2691541B1 (en) | 2011-03-31 | 2017-10-18 | Dana-Farber Cancer Institute, Inc. | Method for enriching in single-stranded mutant sequences from mixture of wild-type and mutant sequences |
| CA2835942C (en) | 2011-05-19 | 2019-01-22 | Sequenom, Inc. | Products and processes for multiplex nucleic acid identification |
| US9238836B2 (en) | 2012-03-30 | 2016-01-19 | Pacific Biosciences Of California, Inc. | Methods and compositions for sequencing modified nucleic acids |
| US9133490B2 (en) | 2012-05-16 | 2015-09-15 | Transgenomic, Inc. | Step-up method for COLD-PCR enrichment |
| CN105189746B (zh) | 2013-03-14 | 2018-12-04 | 宝生物工程株式会社 | 用于使用耐热的错配内切核酸酶的方法 |
| MX364309B (es) | 2013-04-17 | 2019-04-22 | Pioneer Hi Bred Int | Métodos para caracterizar la composición de secuencias de adn en un genoma. |
| WO2015013166A1 (en) | 2013-07-24 | 2015-01-29 | Dana-Farber Cancer Institute, Inc. | Methods and compositions to enable enrichment of minor dna alleles by limiting denaturation time in pcr or simply enable enrichment of minor dna alleles by limiting denaturation time in pcr |
| US9873908B2 (en) | 2013-11-27 | 2018-01-23 | Roche Molecular Systems, Inc. | Methods for the enrichment of mutated nucleic acid from a mixture |
| CA3046953A1 (en) | 2016-12-12 | 2018-06-21 | Dana Farber Cancer Institute, Inc. | Compositions and methods for molecular barcoding of dna molecules prior to mutation enrichment and/or mutation detection |
-
2011
- 2011-03-08 DK DK11709836.8T patent/DK2545189T3/en active
- 2011-03-08 KR KR1020127026077A patent/KR101550489B1/ko not_active Expired - Fee Related
- 2011-03-08 JP JP2012557157A patent/JP5795341B2/ja not_active Expired - Fee Related
- 2011-03-08 CN CN201180020433.8A patent/CN102859003B/zh active Active
- 2011-03-08 US US13/042,549 patent/US8623603B2/en active Active
- 2011-03-08 KR KR1020157014456A patent/KR20150067398A/ko not_active Withdrawn
- 2011-03-08 CA CA2792433A patent/CA2792433C/en active Active
- 2011-03-08 ES ES11709836.8T patent/ES2665500T3/es active Active
- 2011-03-08 AU AU2011224534A patent/AU2011224534B2/en not_active Ceased
- 2011-03-08 EP EP11709836.8A patent/EP2545189B1/en not_active Not-in-force
- 2011-03-08 WO PCT/US2011/027473 patent/WO2011112534A1/en not_active Ceased
-
2013
- 2013-12-16 US US14/107,291 patent/US9957556B2/en active Active
-
2018
- 2018-03-29 US US15/940,274 patent/US11174510B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011224534B2 (en) | 2014-10-09 |
| AU2011224534A1 (en) | 2012-09-27 |
| JP5795341B2 (ja) | 2015-10-14 |
| CA2792433C (en) | 2016-10-11 |
| US8623603B2 (en) | 2014-01-07 |
| KR20120139780A (ko) | 2012-12-27 |
| US20110217714A1 (en) | 2011-09-08 |
| ES2665500T3 (es) | 2018-04-26 |
| CA2792433A1 (en) | 2011-09-15 |
| CN102859003B (zh) | 2014-07-30 |
| KR101550489B1 (ko) | 2015-09-07 |
| CN102859003A (zh) | 2013-01-02 |
| US20140106362A1 (en) | 2014-04-17 |
| JP2013521776A (ja) | 2013-06-13 |
| US20180282798A1 (en) | 2018-10-04 |
| US11174510B2 (en) | 2021-11-16 |
| WO2011112534A1 (en) | 2011-09-15 |
| EP2545189A1 (en) | 2013-01-16 |
| KR20150067398A (ko) | 2015-06-17 |
| EP2545189B1 (en) | 2018-01-10 |
| US9957556B2 (en) | 2018-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2545189T3 (en) | COMPLETE COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE | |
| US9133490B2 (en) | Step-up method for COLD-PCR enrichment | |
| EP2992110B1 (en) | A method for dna amplification with a blocking oligonucleotide | |
| CN107849603B (zh) | 利用有限核苷酸组成的引物扩增 | |
| WO2016210224A1 (en) | Selective degradation of wild-type dna and enrichment of mutant alleles using nuclease | |
| WO2017048863A1 (en) | Step-up method for ice cold-pcr enrichment | |
| US20160201105A1 (en) | Step-up method for cold-pcr enrichment | |
| HK40064470A (en) | Amplification with primers of limited nucleotide composition | |
| WO2023137407A1 (en) | Methods and compositions for fast nucleic acid amplifications |